Drug intelligence / Profile preview

acetylsalicylic acid + loperamide

Development stage
Unknown
Lead developer
Aspire Biopharma
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination of two small molecule drugs, acetylsalicylic acid (commonly known as aspirin) and loperamide. Acetylsalicylic acid is a nonsteroidal anti-inflammatory drug (NSAID) that works by irreversibly inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), leading to decreased synthesis of prostaglandins and thromboxane A2, which results in analgesic, antipyretic, anti-inflammatory, and antiplatelet effects[6]. Loperamide is an antidiarrheal agent that acts as an agonist at mu-opioid receptors in the gut wall to slow intestinal motility and increase absorption of fluids and electrolytes; it does not cross the blood-brain barrier at therapeutic doses[8]. This combination would theoretically provide both symptomatic relief from pain/fever/inflammation (aspirin) and control of diarrhea (loperamide). There are no widely recognized or marketed pharmaceutical products containing this exact combination.

Other names
aspirin + loperamide
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on acetylsalicylic acid + loperamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylsalicylic acid + loperamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call